Today: 20 May 2026
Imperial Brands share price slips as buyback rolls on; AGM clears dividend
29 January 2026
1 min read

Imperial Brands share price slips as buyback rolls on; AGM clears dividend

LONDON, Jan 29, 2026, 08:02 GMT — Regular session

  • Imperial Brands down about 0.3% in early trade, after closing at 3,028p on Wednesday
  • Company disclosed another tranche of share buybacks for cancellation
  • Shareholders backed all AGM resolutions, including the final dividend

Imperial Brands shares edged lower in early London trading on Thursday, with the stock last at 3,019 pence.

The move keeps focus on a familiar driver for the cigarette maker: cash returns. Buybacks and dividends have become the main talking points for a shareholder base that tends to prize yield and steady capital returns over big swings in growth.

It also lands at an awkward moment on the calendar. The company has just come through its annual meeting, and the next few weeks bring dividend milestones that can pull trading flows around the stock.

Imperial said it bought back 289,199 shares on Wednesday at an average price of 3,014.96 pence, with Morgan Stanley acting as broker, according to an RNS filing. The shares will be cancelled.

A day earlier, Imperial reported a further 195,136 shares repurchased for cancellation, also via Morgan Stanley, at an average price of 3,026.93 pence.

Buybacks shrink the share count over time, which can lift earnings per share even if underlying profit holds steady. They can also help dampen volatility on weaker tape, though the daily purchases are usually small against normal volume.

At its annual general meeting on Wednesday, Imperial said all resolutions were passed, including the declaration of a final dividend, with strong support across most votes.

The company’s buyback programme totals £1.45 billion for its 2026 financial year, which it flagged in an earlier trading update alongside its wider plan to keep returning cash to investors.

Rival British American Tobacco was flat early on Thursday, offering little sector lead for Imperial either way.

But there are obvious ways this can go wrong. Tobacco groups still face steady volume declines, shifting rules on nicotine products, and periodic bouts of litigation and tax risk that can override the comfort of buybacks and dividends.

Next up, Imperial’s shares go ex-dividend on Feb. 19, with the final dividend payment slated for March 31. Investors will also be watching for the company’s half-year results on May 12.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus
Previous Story

Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus

HSBC share price slips from record highs as investors weigh Fed pause and Hang Seng move
Next Story

HSBC share price slips from record highs as investors weigh Fed pause and Hang Seng move

Go toTop